NovaMedica’s goal is not only to become a market leader in its key therapeutic areas but mostly to provide patients and doctors with the access to the most advanced and effective products and technologies. Our portfolio includes pharmaceutical and other medical products, diagnostic equipment, medical devices and technologies designed to provide a comprehensive solution for the whole range of interrelated problems and to bring a real value to the Russian patients.
Key development areas of NovaMedica’s product portfolio are:
27 January 2023
A child has been diagnosed with SMA in the neonatal screening that started in 2023
27 January 2023
Enhancing Clinical Trials with More Diverse Recruitment
26 January 2023
WHO pushes for action by manufacturers and governments after warnings over contaminated cough syrups
26 January 2023